A View LCS vs Steth IO

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Coreline Soft
VS
by Steth IO

AI Verdict

Tool A is an AI-powered imaging platform for detailed analysis of thoracic CT scans, focusing on conditions like lung cancer and coronary calcification. Tool B is a smartphone-based digital stethoscope for real-time auscultation, recording, and sharing of heart and lung sounds, primarily enhancing physical exams and telemedicine. While both aid in cardiology and pulmonology diagnostics, they utilize entirely different data sources and methodologies, making them complementary rather than direct competitors.

Choose A View LCS if…

Choose AVIEW LCS if your practice requires advanced, AI-driven analysis of thoracic CT scans for comprehensive lung cancer screening, emphysema quantification, and coronary artery calcification detection. This tool is ideal for radiology, pulmonology, and cardiology departments seeking automated, quantitative insights and detailed reporting from low-dose CT imaging.

View A View LCS →

Choose Steth IO if…

Choose Steth IO if you need a portable, smartphone-integrated solution for real-time auscultation, recording, and sharing of heart and lung sounds, especially for telemedicine and remote patient monitoring. This tool is best suited for healthcare providers looking to enhance diagnostic accuracy and facilitate virtual consultations with immediate sound visualization and secure sharing capabilities.

View Steth IO →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature A View LCS Steth IO
Pricing Unknown Customized pricing; subscription-based for steth io spot.
Deployment Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). It can also be integrated into standard reading environments (PACS), RIS (Radiological Information System), or used as a standalone third-party application or web-based application. Cloud-based
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Steth IO

Steth IO leverages the ubiquity and familiarity of smartphones for real-time, point-of-care diagnostics, making it highly accessible and intuitive for a broad range of healthcare providers. While A View LCS automates complex imaging analysis, Steth IO's integration with a mobile device for immediate diagnostic aid offers a more universally 'usable' experience.

Clinical Value

A View LCS

A View LCS offers quantitative analysis for the diagnosis and risk stratification of life-threatening conditions like lung cancer, emphysema, and coronary artery disease from CT scans, directly impacting critical clinical decision-making. While Steth IO enhances a fundamental diagnostic skill and supports telemedicine, A View LCS's impact on specific disease diagnosis and management pathways appears more profound.

Pricing & Value

Steth IO

Steth IO provides more transparent pricing information, including a specific subscription model for individual use, which indicates a clearer value proposition and potentially lower barrier to entry for some users. A View LCS's 'contact for quote' offers no immediate insight into its cost-effectiveness.

Enterprise Readiness

A View LCS

A View LCS explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement (BAA), alongside robust and flexible deployment options designed for enterprise environments. Steth IO's statement regarding user responsibility for HIPAA compliance and warnings about data sharing methods present potential challenges for large-scale institutional integration and compliance.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. A View LCS pushes the boundaries of AI in medical imaging analysis with its comprehensive CT interpretation and kernel conversion technology. Steth IO innovatively leverages ubiquitous smartphone technology to democratize advanced auscultation and integrate it with telemedicine, offering a disruptive approach to point-of-care diagnostics.

Support & Docs

Steth IO

Steth IO clearly outlines direct support channels via email and provides explicit user documentation such as a 'User's Guide' and 'Instruction Manual'. While Coreline Soft offers technical brochures for A View LCS, Steth IO's readily accessible and clearly defined support resources and user guides provide a more transparent and direct support experience.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature A View LCS Steth IO
Product Name A View LCS Steth IO
Company Coreline Soft Co. STRATOSCIENTIFIC
Primary Function AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. FDA-cleared smartphone stethoscope that transforms a mobile device into a powerful diagnostic aid for hearing, visualizing, recording, and sharing heart and lung sounds.
Key Feature Example Automated lung nodule detection and classification; Nodule volume quantification and measurement (3D); Lung-RADS scoring and reporting. Real-time visualization of heart and lung sounds (phonocardiogram/spectrogram); Record and save patient exams; Share exams with specialists/other healthcare providers.

Videos

Demos, reviews, and walkthroughs featuring A View LCS and Steth IO.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AVIEW LCS is an FDA-cleared AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. Steth IO is an FDA-cleared smartphone stethoscope that transforms a mobile device into a diagnostic aid, enabling healthcare providers to hear, visualize, record, and share heart and lung sounds in real-time.
AVIEW LCS analyzes data from low-dose CT scans to provide automated detection and quantification of thoracic conditions. Steth IO captures real-time heart and lung sounds via a smartphone-powered stethoscope, which can then be visualized as a phonocardiogram or spectrogram and recorded.
AVIEW LCS is focused on CT analysis and reporting, which can support remote diagnostics. Steth IO is specifically designed with telemedicine capabilities, including live auscultation and video calls, and facilitates remote patient monitoring through its ability to record and share exams.
AVIEW LCS generates automated comprehensive reports including Lung-RADS scoring, emphysema quantification (LAA), and coronary artery calcium (CAC) scoring (Agatston, volume, mass). Steth IO provides real-time visualization of heart and lung sounds (phonocardiogram/spectrogram), recorded patient exams, and an annotation tool for adding notes to exams.
AI Tool Finder
AI-powered search. Results may not be comprehensive.